Is Bempedoic Acid Fda Approved
Is Bempedoic Acid Fda Approved. A novel, oral drug, bempedoic acid, safely cut ldl cholesterol levels by almost 20% in patients who had maxed out their statin treatment, in a pivotal trial with more than 2,000 patients. The label recommends analyzing lipid levels within 8 to 12 weeks of initiation and to avoid concomitant use of bempedoic acid with simvastatin greater than 20 mg and with pravastatin greater than 40 mg.
According to the prescribing information, the approved therapy is a combination of bempedoic acid 180 mg and ezetimibe 10 mg. Bempedoic acid has been studied four phase iii clinical trials representing more than 3,600 patients. Swelling of your face, lips, tongue, or throat.
Yes (First Approved February 21, 2020) Brand Name:
As an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or established atherosclerotic This draft guidanc e, when finalized, will represent the current thinking of the food and drug administration (fda, or th e agency) on this topic. Bempedoic acid is an additional treatment option, along with both statins and diet and exercise, for reducing cholesterol levels and ascvd events.
According To The Prescribing Information, The Approved Therapy Is A Combination Of Bempedoic Acid 180 Mg And Ezetimibe 10 Mg.
The label recommends analyzing lipid levels within eight to 12 weeks of initiation and to avoid concomitant use of bempedoic acid with simvastatin greater than 20 mg and with pravastatin greater than 40 mg. A novel, oral drug, bempedoic acid, safely cut ldl cholesterol levels by almost 20% in patients who had maxed out their statin treatment, in a pivotal trial with more than 2,000 patients. It is a combination of bempedoic acid and ezetimibe.
Laboratory Test Values Returned To Baseline Following Discontinuation
The label recommends analyzing lipid levels within 8 to 12 weeks of initiation and to avoid concomitant use of bempedoic acid with simvastatin greater than 20 mg and with pravastatin greater than 40 mg. Bempedoic acid has been studied four phase iii clinical trials representing more than 3,600 patients. Stop taking bempedoic acid and seek medical attention right away if you have signs of tendon rupture:.
T H E Use Of The Word Should In Fda Guidances Means That Something Is Suggested Or Recommended, But Not Required.
The safety and efficacy of bempedoic acid were demonstrated over 52 weeks in two multicenter randomized, clinical trials involving 3,009. Bempedoic acid/ezetimibe was approved in the united states in february 2020, and in the european union in march 2020. Can acc/aha guidelines be compared with atp iii?
Is Bempedoic Acid Fda Approved?
This new drug application provides for the use of nexletol (bempedoic acid) tablets. Bempedoic acid is currently fda approved as an adjunct to diet and maximally tolerated statin therapy for the treatment of hyperlipidemia and cardiovascular outcomes trials evaluating the impact of bempedoic acid on hard cardiovascular endpoints. The fda approved nexletol based on evidence from two clinical trials (trial 1.
Comments
Post a Comment